We have previously generated two mouse mutants carrying distinct glia-related mutations in the PLP1 gene [8] that have initially been identified in patients fulfilling clinical criteria for multiple sclerosis (MS) [9, 10], a neurological CNS disorder known to be related to detrimental neuroinflammation [11, 12]. The gene discussed is PLP1; the disease is myeloid sarcoma.